One ‐year outcomes of pulmonary vein isolation with a novel cryoballoon: Primary results of the FROZEN AF trial

ConclusionsThis novel cryoballoon may facilitate PVI to treat PAF, providing more options to address the variety of anatomies present in patients with PAF. This cryoballoon system proved to be safe and effective for treatment of patients with drug refractory or drug intolerant PAF.

Source: Journal of Cardiovascular Electrophysiology - March 7, 2024 Category: Cardiology Authors: Kenneth A. Ellenbogen, Suneet Mittal, Niraj Varma, Arash Aryana, Nassir Marrouche, Ante Ani ć, Devi Nair, Jean Champagne, Saverio Iacopino, Carlo de Asmundis, Stanislav Weiner, Kevin Makati, Jonathan D. Raybuck, Elizabeth Richards, Wilber S Tags: ORIGINAL ARTICLE Source Type: research